ArticleOncotarget2026

Retraction: MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.

Songyu Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.